Identification of an immunodominant neutralizing epitope of porcine Deltacoronavirus spike protein
Rui Chen,Yimin Wen,Enbo Yu,Junpeng Yang,Yixiao Liang,Daili Song,Yiping Wen,Rui Wu,Qin Zhao,Senyan Du,Qigui Yan,Xinfeng Han,Sanjie Cao,Xiaobo Huang
DOI: https://doi.org/10.1016/j.ijbiomac.2023.125190
IF: 8.2
2023-06-08
International Journal of Biological Macromolecules
Abstract:Porcine deltacoronavirus (PDCoV) is a novel swine enteropathogenic coronavirus that, because of its broad host range, poses a potential threat to public health. Here, to identify the neutralizing B-cell epitopes within the S1-CTD protein, we generated three anti-PDCoV monoclonal antibodies (mAbs). Of these, the antibody designated 4E-3 effectively neutralized PDCoV with an IC50 of 3.155 μg/mL. mAb 4E-3 and one other, mAb 2A-12, recognized different linear B-cell epitopes. The minimal fragment recognized by mAb 4E-3 was mapped to 280 FYSDPKSAV 288 and designated S 280–288 , the minimal fragment recognized by mAb 2A-12 was mapped to 506 TENNRFTT 513 , and designated S 506–513 . Subsequently, alanine (A)-scanning mutagenesis indicated that Asp 283 , Lys 285 , and Val 288 were the critical residues recognized by mAb 4E-3. The S 280–288 epitope induces PDCoV specific neutralizing antibodies in mice, demonstrating that it is a neutralizing epitope. Of note, the S 280–288 coupled to Keyhole Limpet Hemocyanin (KLH) produces PDCoV neutralizing antibodies in vitro and in vivo , in challenged piglets it potentiates interferon-γ responses and provides partial protection against disease. This is the first report about the PDCoV S protein neutralizing epitope, which will contribute to research of PDCoV-related pathogenic mechanism, vaccine design and antiviral drug development.
polymer science,biochemistry & molecular biology,chemistry, applied